CardioNerds
CardioNerds
Advertisement
Amit Goyal, MDInterventional Cardiology | June 13, 2025
OCTIVUS shows PCI outcomes improve with EAPCI-defined stent optimization, regardless of imaging modality.
Read More
CardioNerdsHeart Failure | June 12, 2025
MITT and safety data show acoramidis significantly lowers AFib-related events in transthyretin cardiac amyloidosis.
Amit Goyal, MDInterventional Cardiology | June 11, 2025
LuX-Valve offers a safe, effective option for severe TR patients at high surgical risk.
CardioNerdsHeart Failure Congress 2025 | June 5, 2025
ESC 2025: Acoramidis may reduce AF/flutter burden in ATTR-CM, per new ATTRibute-CM trial analysis discussed by CardioNerds.
Amit Goyal, MDInterventional Cardiology | May 29, 2025
CTA-first screening before TAVR avoids invasive angiography in 53% of patients—without compromising outcomes.
Amit Goyal, MDCardioNerds | May 28, 2025
Delays in TAVI for acute decompensated aortic stenosis worsen outcomes.
CardioNerdsCardioNerds | May 15, 2025
Explore evolving LV unloading strategies in AMI shock with The CardioNerds.
CardioNerdsCardioNerds | May 15, 2025
Pulmonary air embolism causing RV failure & arrest—via ocular route? A rare case, deep dive, with The CardioNerds.
Amit Goyal, MDCardioNerds | May 14, 2025
NAVULTRA registry compares Navitor vs. SAPIEN 3 Ultra in TAVR, revealing key tradeoffs in pacemaker use, PVL, and HF outcomes
CardioNerdsCardioNerds | May 12, 2025
Dr. Daniel Judge discusses how the ATTRibute-CM trial marks a turning point in ATTR cardiomyopathy treatment and research.
Amit Goyal, MDInterventional Cardiology | May 16, 2025
The FDA approved the use of Edwards Lifesciences' SAPIEN 3 TAVR platform for patients with severe aortic stenosis.
CardioNerdsCardioNerds | May 2, 2025
Dr. Dan Judge speaks to The CardioNerds about his interpretation of the primary findings from ATTRibute-CM.
CardioNerdsCardioNerds | May 5, 2025
Dr. Daniel Judge talks to the CardioNerds about a pivotal study in ATTR-CM.
Rob DillardACC.25: Focus on ATTR-CM | April 30, 2025
A multifaceted approach is necessary to reduce the deaths of smoking-related aortic aneurysms.
Rob DillardACC.25: Focus on ATTR-CM | April 29, 2025
Many preschool-aged children with congenital heart conditions are not on track for school readiness.
CardioNerdsCardioNerds | May 2, 2025
The CardioNerds talk about the professional challenges ACHD providers face across the lifespan of congenital heart disease.
Amit Goyal, MDCardiology | April 9, 2025
Dr. Amit Goyal of the CardioNerds analyzed the BHF PROTECT-TAVI trial.
Amit Goyal, MDCardioNerds | May 16, 2025
The REPAIR study offers the most comprehensive real-world assessment of outcomes after mitral TEER.
CardioNerdsCardiology | March 27, 2025
The CardioNerds, along with colleagues detail a case involving a patient with newly diagnosed hypertriglyceridemia.
Amit Goyal, MDInterventional Cardiology | May 16, 2025
The ROLLER COASTR-EPIC22 trial is the first randomized head-to-head comparison of three plaque modification techniques.
Advertisement
Advertisement